United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - reclipsen™ (desogestrel and ethinyl estradiol tablets usp) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with reclipsen (desogestrel and ethinyl estradiol tablets usp), 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. table 1: percentage of women experiencing an unintended pregnancy during the first year of typi

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - reclipsen™ (desogestrel and ethinyl estradiol tablets usp) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with reclipsen (desogestrel and ethinyl estradiol tablets usp), 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. table 1: percentage of women experiencing an unintended pregnancy during the first year of typi

Canada - English - Health Canada

actavis pharma company - desogestrel; ethinyl estradiol - tablet - 0.15mg; 0.03mg - desogestrel 0.15mg; ethinyl estradiol 0.03mg - contraceptives

Canada - English - Health Canada

actavis pharma company - desogestrel; ethinyl estradiol - tablet - 0.15mg; 0.03mg - desogestrel 0.15mg; ethinyl estradiol 0.03mg - contraceptives

Singapore - English - HSA (Health Sciences Authority)

ipsen pharma singapore pte. ltd. - clostridium botulinum type a toxin-haemagglutinin complex - injection, powder, for solution - 500 u/vial - clostridium botulinum type a toxin-haemagglutinin complex 500 u/vial

Singapore - English - HSA (Health Sciences Authority)

ipsen pharma singapore pte. ltd. - triptorelin pamoate eqv. triptorelin - injection, powder, for suspension, extended release - 11.25 mg/vial - triptorelin pamoate eqv. triptorelin 11.25 mg/vial

Singapore - English - HSA (Health Sciences Authority)

ipsen pharma singapore pte. ltd. - clostridium botulinum type a toxin-haemagglutinin complex - injection, powder, for solution - clostridium botulinum type a toxin-haemagglutinin complex 300u/vial

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.15 mg

Malta - English - Medicines Authority

ipsen pharma 65 quai georges gorse, 92100 boulogne-billancourt,, france - powder for solution for injection - botulinum toxin type a 125 u - muscle relaxants

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ipsen ltd - cabozantinib s-malate - tablet - 20mg